Sanmina Corporation heads into mid-May with a striking tension between a blistering 60% one-month price run and a wave of insider selling that accelerated at the top.
The standout story this week is what insiders are doing with the rally. Founder, Chairman and CEO Jure Sola sold 118,368 shares on May 6 at $228.84, banking just over $27 million in a single transaction. That is by far the largest insider move in the recent log. An independent director, Joseph Licata, sold a combined $5.6 million across two tranches on April 29, while EVP Alan Reid has been selling in steady 1,000-share clips across multiple sessions. The Chief Accounting Officer and another independent director have also trimmed. In aggregate, net insider activity over the 90-day window totals a net sale of roughly $37.4 million in value — directionally one-sided, with no offsetting purchases anywhere in the record. AMD Ventures, notably, appeared in a freshly filed 13F holding 1.15 million shares, a position worth tracking given its strategic relationship with the company.
Borrow market conditions tell a calm story that sits at odds with the volume of insider activity. Short interest is modest at just under 5% of the free float — a level that has actually drifted lower over the past month, down roughly 4.6%. Availability in the lending market is loose, and the cost to borrow has nudged up about 16% on the week to 0.48% APR, but that remains a near-frictionless rate for anyone wanting to establish a short position. The ORTEX short score of 42.1 is mid-range and has been gently declining since late April's brief spike toward 43.2. None of the short-side signals are flashing urgency.
Options positioning has tilted slightly more defensive following the surge. The put/call ratio climbed to 0.24 this week, running roughly 1.7 standard deviations above its 20-day mean of 0.15. That is not extreme by historical standards — the 52-week high for the PCR is nearly 6.0 — but it is a noticeable shift from the calls-dominated skew that characterised April's rally. Traders appear to be adding some downside protection at elevated price levels, consistent with the general mood after a near-vertical one-month move. Closest US peer JBL fell 4% on the day versus SANM's 3.9% decline, suggesting sector-level selling pressure was the driver rather than anything company-specific.
The analyst picture requires a note of caution. JP Morgan initiated coverage in late March with a Neutral rating and a $145 target — well below the current $235.84 print — while Argus Research was more constructive in January with a Buy and a $200 target. The consensus mean price target of $212 sits roughly 10% below the current price. Given the stock's 60% one-month move, that inversion — where the stock now trades above Street targets — is itself a data point. The EV/EBITDA multiple has risen sharply over 30 days, though the P/E of roughly 19.9x remains reasonable for a contract manufacturer. Valuation has been re-rated meaningfully by the market, but analyst targets have not caught up.
Earnings provided the initial spark. SANM printed a 12% one-day gain on April 28 following its Q2 results, and the five-day reading was equally strong at 12.7%. The stock has extended those gains further in the weeks since. No next earnings date is currently confirmed in the system. BlackRock and FMR LLC together control nearly 29% of shares, and both added to positions in the most recent reported period — a base of institutional support that helped validate the post-earnings move.
The key variable to watch now is whether analyst targets start moving toward current levels, or whether the gap between Street consensus and the stock price begins to weigh on momentum as the initial post-earnings excitement fades.
See the live data behind this article on ORTEX.
Open SANM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
